On June 10 and 11, several tech and biotech firms, including Real Messenger, Tango Therapeutics, Almonty, and Shattuck Labs, closed or priced significant offerings to boost liquidity. Meanwhile, SpaceX finalized its IPO price at $135 per share, with retail investor orders remarkably exceeding $100 billion. Despite this demand, there are formal calls for the SEC to delay the SpaceX IPO to ensure market integrity and investor protection.
